GlassScriptPhysician profile
Ryan Larsen
NPI 1972103885
$4,696.35
in general payments reported to CMS, 2019-2025
20 companies · $908 in 2025
The $908 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,789 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,654 · Food and Beverage: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,653.84 |
| Food and Beverage | $2,042.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $2,132.44 | 2024-2025 | |
| Stryker Corporation | $1,845.71 | 2024-2025 | Ortholoc 3di, Ortholoc 2 Lapifuse, Hoffmann |
| Ani Pharmaceuticals, INC. | $127.87 | 2024-2025 | Purified Cortrophin Gel |
| Paratek Pharmaceuticals, INC. | $125.00 | 2024 | Nuzyra |
| Depuy Synthes Sales INC. | $56.15 | 2024-2025 | Motoband, Healix Knotless Peek, Dynatape |
| Mimedx Group, INC. | $51.33 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $48.19 | 2025 | |
| Medtronic, INC. | $44.16 | 2024-2025 | Venaseal, Intellis Adaptivestim |
| Smith+Nephew, INC. | $40.69 | 2024-2025 | Stravix Pl, Grafix Pl, Collagenase Santyl |
| Reprise Biomedical, INC. | $34.08 | 2025 | Miro3d |
| Abbott Laboratories | $24.72 | 2024 | Proclaim |
| Averitas Pharma INC. | $23.62 | 2025 | Qutenza |
| Kerecis Limited | $22.95 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Crossroads Orthopedics, LLC | $20.39 | 2024 | |
| Orthofix Medical, INC. | $19.25 | 2025 | Physio-Stim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $17.12 | 2024 | Novosorb Btm |
| Treace Medical Concepts, INC. | $16.32 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $15.79 | 2024 | Exparel, Iovera |
| Amgen INC. | $15.65 | 2024 | Krystexxa |
| Paragon 28, INC. | $14.92 | 2024 | Gorilla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.